Ticker Hub
KMDA — AI Analysis & Sentiment
4 recent AI-generated analyses for KMDA. Sentiment and confidence insights updated continuously.
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
Kamada's FDA approval for its in-house rabies testing lab improves efficiency for a core product, potentially boosting margins. The market has not ...
Jun 1, 2026Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
Kamada's FDA approval for its San Antonio plasma center is a key operational milestone, enabling new revenue streams and supporting its growth stra...
Mar 26, 2026Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy
Kamada's declaration of a cash dividend and adoption of an annual dividend policy signals a commitment to shareholder returns, likely attracting in...
Mar 11, 2026Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth
Kamada's robust 2025 financial performance and optimistic 2026 guidance confirm its strong operational execution. The declaration of a dividend fur...
Mar 11, 2026